Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids

Nutrition and Cancer

Volumn 34, Issue 2, 1999, Pages 199-205

  Foehr, Matthew W ^a   Tomei, L David ^a   Goddard, Graham ^a   Pemberton, Philip A ^a   Bathurst, Ian C ^a  

^a LXR Biotechnology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOWMAN BIRK INHIBITOR; CHYMOTRYPSIN; LIPID; PHOSPHOLIPID; PROTEIN; TRYPSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCLAVE; CONTROLLED STUDY; DRUG ACTIVITY; EMBRYO; ENZYME INHIBITION; FIBROBLAST; FRACTIONATION; LIPID ANALYSIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; SOYBEAN;

ANIMALIA; GLYCINE MAX;

EID: 0032730656     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3402_11     Document Type: Article

References (44)

1. Tomei, LD, and Cope, FO (Eds): Apoptosis: The Molecular Basis of Cell Death. New York: Cold Spring Harbor Laboratory, 1991.
2. Barr, PJ, and Tomei, LD: Apoptosis and its role in human disease. Biotechnology 12, 487-492, 1994.
3. Barry, MA, Behnke, CA, and Eastman, A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem Pharmacol 40, 2353-2362, 1990.
4. Weil, MM, Stephens, LC, Amos, C, Ruifrok, AC, and Mason, KA: Strain difference in jejunal crypt cell susceptibility to radiation-induced apoptosis. Int J Radiat Biol 70, 579-585, 1996.
5. Funk-Archuleta, MA, Foehr, MW, Tomei, LD, Hennebold, KL, and Bathurst, IC: A soy-derived antiapoptotic fraction decreases methotrexate toxicity in the gastrointestinal tract of the rat. Nutr Cancer 29, 217-221, 1997.
6. Logvinova, AV, Foehr, MW, Pemberton, PA, Khazalpour, KM, Funk-Archuleta, MA, et al.: Soy-derived anti-apoptotic fractions protect gastrointestinal epithelium from damage caused by methotrexate treatment in rat. Nutr Cancer 33, 33-39, 1999.
7. Bathurst, IC, Bradley, JD, Goddard, JG, Foehr, MW, Shapiro, JP, et al.: Soy (glycine-max)-derived phospholipids exhibit potent antiapoptotic activity. Pharm Biol 36, 111-123, 1998.
8. Umansky, SR, Shapiro, JP, Cuenco, GM, Foehr, MW, Bathurst, IC, et al.: Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated ischemia and reperfusion. Cell Death Differ 4, 608-616, 1997.
9. Kennedy, AR: The evidence for soybean products as cancer preventative agents. J Nutr 125, 733S-743S, 1995.
10. Wang, TT, Sathyamoorthy, N, and Phang, JM: Molecular effects of genistein on estrogen receptor-mediated pathways. Carcinogenesis 17, 271-275, 1996.
11. Pagliacci, MC, Smacchia, M, Migliorati, G, Grignani, F, Riccardi, C, et al.: Growth-inhibitory effects of the natural phyto-estrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30, 1675-1682, 1994.
12. Raines, EW, and Ross, R: Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J Nutr 125, 624S-630S, 1995.
13. Chevreau, N, and Funk-Archuleta, M: Effect of enteral formulas on methotrexate toxicity. Nutr Cancer 23, 185-204, 1995.
14. Funk, MA, and Baker, DH: Effect of soy products on methotrexate toxicity in rats. J Nutr 121, 1684-1692, 1991.
15. Funk, MA, and Baker, DH: Effect of fiber, protein source and time of feeding on methotrexate toxicity in rats. J Nutr 121, 1673-1683, 1991.
16. McArdle, AH, Wittnich, C, Freeman, CR, and Duguid, WP: Elemental diet as prophylaxis against radiation injury. Arch Surg 120, 1026-1032, 1985.
17. McArdle, AH, Reid, EC, Laplante, MP, and Freeman, CR: Prophylaxis against radiation injury. Arch Surg 121, 879-885, 1986.
18. Chlebowski, RT, Beall, G, Grosvenor, M, Lillington, L, Weintraub, N, et al.: Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial. Nutrition 9, 507-512, 1993.
19. Birk, Y: The Bowman-Birk inhibitor: trypsin and chymotrypsin inhibitor from soybeans. Int J Peptide Protein Res 25, 113-131, 1985.
20. Kennedy, AR, and Little, JB: Effects of protease inhibitors on radiation transformation in vitro. Cancer Res 41, 2103-2108, 1981.
21. 3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors. Proc Natl Acad Sci USA 84, 4801-4805, 1987.
22. Kennedy, AR: Prevention of Carcinogenesis by protease inhibitors. Cancer Res 54, 1999s-2005s, 1994.
23. Kennedy, AR, Beazer-Barclay, Y, Kinzler, KW, and Newberne, PM: Suppression of Carcinogenesis in the intestines of mm mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res 56, 679-682, 1996.
24. Yavelow, J, Collins, M, Birk, Y, Troll, W, and Kennedy, AR: Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc Natl Acad Sci USA 82, 5395-5399, 1985.
25. Evans, SM, Van Winkle, T, Szuhaj, BF, Michel, KE, and Kennedy, AR: Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57B1/6NCr1BR mice by an autoclave resistant factor present in soybeans. Radiat Res 132, 259-262, 1992.
26. Billings, PC, and Habres, JM: A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc Natl Acad Sci USA 89, 3120-3124, 1992.
27. 3H/10T1/2 cells. Cancer Lett 49, 153-163, 1990.
28. Tikhonova, TV, Gladysheva, IP, and Larionova, NI: Retardation by the soybean Bowman-Birk inhibitor of elastin hydrolysis catalyzed by leukocyte proteinases. FEBS Lett 362, 225-228, 1995.
29. Ware, JH, Wan, XS, Rubin, H, Schechter, NM, and Kennedy, AR: Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch Biochem Biophys 344, 133-138, 1997.
30. Clark, DA, Day, R, Seidah, N, Moody, TW, Cuttitta, F, et al.: Protease inhibitors suppress in vitro growth of human small cell lung cancer. Peptides 14, 1021-1028, 1993.
31. Kennedy, CW, Donahue, JJ, and Wan, XS: Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum. Nutr Cancer 26, 209-217, 1996.
32. Wan, XS, Hamilton, TC, Ware, JH, Donahue, JJ, and Kennedy, AR: Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells. Nutr Cancer 31, 8-17, 1998.
33. Kassell, B: Trypsin and chymotrypsin inhibitors from soybeans. Methods Enzymol 19, 860-861, 1970.
34. Bligh, EG, and Dyer, WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-914, 1959.
35. Tigyi, G, and Meledi, G: Lysophosphatates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 267, 21360-21367, 1992.
36. Abramovitz, AS, Yavelow, J, Randolf, V, and Troll, W: Inhibition of superoxide production in human neutrophils by purified soybean polypeptides. Revaluation of the involvement of proteases. J Biol Chem 258, 15153-15157, 1983.
37. Tomei, LD, Shapiro, JP, and Cope, FO: Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 90, 853-857, 1993.
38. Potten, CS, Merritt, A, Hickman, J, Hall, P, and Farranda, A: Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int J Radiat Biol 65, 71-78, 1994.
39. Ruifrok, AC, Weil, MM, Thames, HD, and Mason, KA: Diurnal variations in the expression of radiation-induced apoptosis. Radiat Res 149, 360-365, 1998.
40. Potten, CS, and Grant, HK: The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer 78, 993-1003, 1998.
41. Milas, L, Stephens, LC, and Meyn, RE: Relation of apoptosis to cancer therapy. In Vivo 8, 665-673, 1994.
42. Cece, R, Barajon, I, and Tredici, G: Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line. Anticancer Res 15, 777-782, 1995.
43. Takeda, M, Fukuoka, K, and Endou, H: Cisplatin-induced apoptosis in mouse proximal tubular cell line. Contrib Nephrol 118, 24-28, 1996.
44. Raaphorst, GP, Mao, J, Yang, H, Goel, R, Niknafs, B, et al.: Evaluation of apoptosis in four human tumor cell lines with differing sensitivities to cisplatin. Anticancer Res 18, 2945-2951, 1998.